Skip to main content
HR 2557 115th Congress House

Prostate Cancer Misdiagnosis Elimination Act of 2017

Official title: To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of certain DNA Specimen Provenance Assay clinical diagnostic laboratory tests.

Introduced: May 19, 2017 See on congress.gov
Health CancerGeneticsGovernment information and archivesHealth information and medical records
More subjectsShow fewer subjects
Medical tests and diagnostic methodsMedicare
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 6, 2017
Placed on the Union Calendar, Calendar No. 331.
Dec 6, 2017
Committee on Ways and Means discharged.
Dec 6, 2017
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.
Oct 4, 2017
Ordered to be Reported (Amended) by Voice Vote.
Oct 4, 2017
Committee Consideration and Mark-up Session Held.
Sep 13, 2017
Forwarded by Subcommittee to Full Committee by Voice Vote .
Sep 13, 2017
Subcommittee Consideration and Mark-up Session Held.
Jun 1, 2017
Referred to the Subcommittee on Health.
May 26, 2017
Referred to the Subcommittee on Health.
May 19, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 6, 2017

Placed on the Union Calendar, Calendar No. 331.

 Plain-English summary Congressional Research Service

Prostate Cancer Misdiagnosis Elimination Act of 2017

This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

 Related & companion bills 1
  • S 2067 Related bill Prostate Cancer Misdiagnosis Elimination Act of 2017
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 1
Brooks, Susan
· Sep 13, 2017
 D
Carson, André
Indiana · May 19, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2557: Prostate Cancer Misdiagnosis Elimination Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2557/
MLA
"H.R. 2557: Prostate Cancer Misdiagnosis Elimination Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2557/.
Bluebook (legal)
H.R. 2557, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2557/.
Markdown link
[H.R. 2557: Prostate Cancer Misdiagnosis Elimination Act of 2017](https://openamerica.io/bill/115-HR-2557/)
Report a problem